Abstract: Modular fluid path assemblies are provided that include conduit, coupling, and needle portions of a fluid path fluidly coupled to an outlet of a container. The modular fluid path assemblies further include a needle shield having a tip of the needle embedded therein. So configured, in embodiments, the modular fluid path assemblies can be sterilized, a medicament can be filled in the container, and a stopper inserted in the container so that the pre-sterilized and pre-filled modular fluid path assemblies can have a closed container integrity (CCI) seal.

Abstract: A method for controlling an Air Handling Unit (AHU) of an HVAC (Heating, Ventilating and Air Conditioning) system servicing a building space of a building includes determining when there is an elevated pathogen transmission risk in the building space. In response to determining that there is an elevated pathogen transmission risk in the building space, the AHU is controlled to adjust operation of the AHU to alleviate the elevated pathogen transmission risk.

Abstract: Devices, methods, and systems for monitoring and/or assessing compliance with infectious disease guidance for reducing infectious disease transmissions are described herein. The systems may include sensing devices at or within a facility and computing devices to compare data based on outputs from the sensing devices with guidance and/or recommendations for mitigating infectious disease transmission. Various compliance parameters may be identified as being relevant to the guidelines and measurable with outputs from the sensing devices. Various compliance parameters may be identified as being relevant to the guidelines, but not measurable with outputs from the sensing devices. The compliance parameters may be individually scored or scored in groups, including the compliance parameters not measureable with outputs from the sensing devices, and a score relative to a facility or group of facilities may be provided. The scores may be presented to via a dashboard.

Abstract: In some examples, a first computing device may receive a first request from a second computing device. For example, the first computing device may be able to communicate with a plurality of database nodes, each database node maintaining a portion of a database distributed across the plurality of database nodes. Further, the first computing device may maintain a local cache of a subset of information maintained in the database. The first computing device may send a second request based on the first request to a first database node to cause the first database node to change the data in the database. In addition, the first computing device receives, from a message queue of a plurality of distributed message queues, a cache update message based on the change to the data in the database. The first computing device may update the local cache based on the cache update message.

Abstract: Drug delivery devices are described that include an escapement activation assembly. The escapement activation assembly includes a slide having a plurality of pallet engagement portions and a switch engagement portion and a pallet having a plurality of slide engagement portions. A drive is coupled to the pallet to cause the pallet to move relative to the slide to move the plurality of slide engagement portions into and out of engagement with the plurality of pallet engagement portions to allow the slide to move along a path within the drug delivery device. Movement of the slide can cause the switch engagement portion to move out of engagement with an activation trigger of a mechanism of the drug delivery device.

Abstract: An injection device, method, and system for drug delivery includes a primary container for storing a drug, the container having a stopper movably disposed in the container for expelling the drug, an injection drive mechanism comprising a plunger for acting on the stopper and an energy source for exerting a force on the plunger to cause the plunger to act on the stopper to expel the drug, the force causing the plunger to accelerate to a velocity prior to acting on the stopper, and a damping mechanism for reducing the velocity of the plunger prior to acting on the stopper. The damping mechanism can include a dashpot or an energy absorbing material associated with the plunger. Alternatively or additionally, the damping mechanisms can include absorbing material disposed between support members of an outer casing of the injection device and the primary container.

Abstract: Systems and methods for delayed delivery of a drug are disclosed. A drug delivery system may include a delivery member for insertion into a patient and a reservoir configured to receive a volume of a drug. An energy source may be activatable by the patient to actuate the reservoir to deliver the drug to the patient as a single bolus. A lockout system may be configured to have a locked state, wherein the lockout system prevents movement of the delivery member and/or activation of the energy source, and an unlocked state, wherein the lockout system permits movement of the delivery member and/or activation of the energy source. The lockout system may be configured to automatically change from the locked state to the unlocked state after a preselected time period has elapsed. An output element may generate a detectable output after the preselected time period has elapsed for notifying the patient.

Abstract: In some examples, a first computing device may receive a first request from a second computing device. For example, the first computing device may be able to communicate with a plurality of database nodes, each database node maintaining a portion of a database distributed across the plurality of database nodes. Further, the first computing device may maintain a local cache of a subset of information maintained in the database. The first computing device may send a second request based on the first request to a first database node to cause the first database node to change the data in the database. In addition, the first computing device receives, from a message queue of a plurality of distributed message queues, a cache update message based on the change to the data in the database. The first computing device may update the local cache based on the cache update message.

Abstract: Systems and methods for injecting a drug and detecting tissue induced back pressure are disclosed. A drug delivery system may include a reservoir filled or fillable with a drug, an administration member connected or connectable in fluid communication with the reservoir, a drive assembly, and a pressure sensor. The administration member may be configured for insertion into and subsequently retraction from a patient. The drive assembly may be configured to urge the drug from the reservoir to deliver a dose of the drug to the patient via the administration member. The pressure sensor may be configured to detect tissue back pressure during use of the drug delivery system, including after dose completion and prior to retraction of the administration member. The drug delivery system may be controlled in a manner that accounts for the tissue back pressure measurement.

Abstract: Systems and methods for delayed delivery of a drug are disclosed. A drug delivery system may include a delivery member for insertion into a patient and a reservoir configured to receive a volume of a drug. An energy source may be activatable by the patient to actuate the reservoir to deliver the drug to the patient as a single bolus. A lockout system may be configured to have a locked state, wherein the lockout system prevents movement of the delivery member and/or activation of the energy source, and an unlocked state, wherein the lockout system permits movement of the delivery member and/or activation of the energy source. The lockout system may be configured to automatically change from the locked state to the unlocked state after a preselected time period has elapsed. An output element may generate a detectable output after the preselected time period has elapsed for notifying the patient.

Abstract: Systems and methods for drug delivery with pressure sensitive control are disclosed. A drug delivery system may include a reservoir filled or fillable with a drug, a drug delivery device coupled to the reservoir to deliver the drug from the reservoir to a patient, a pressure sensor, an output device, and a controller. The controller may be configured to determine if the drug delivery device has completed delivering a dose of the drug to the patient, and if delivery of the dose of the drug is complete, to measure tissue back pressure using the pressure sensor. Subsequently, the controller may be configured to determine if the tissue back pressure is below a first predetermined value, and if so, control the output device at least once and/or control a mechanism to retract an administration member from the patient.

Abstract: A drug delivery device includes a housing, a container disposed in the housing, an activation mechanism, a needle insertion mechanism, a fluid flow connection, and a valve in fluid communication with the fluid flow connection and the needle insertion mechanism. The container has an inner volume to contain a medicament which is urged out of the container by the activation mechanism. The needle insertion mechanism is adapted to insert a needle and/or a cannula to deliver the medicament from the container via the fluid flow connection. The valve is in fluid communication with the fluid flow connection and needle insertion mechanism, and is movable between first and second positions. Upon insertion of the needle and/or the cannula, the valve remains in the first position whereby fluid flow is restricted. At a later time, the valve is urged to the second position whereby fluid may flow through the needle or cannula.

Abstract: A drug delivery device includes a housing, a container disposed in the housing, an activation mechanism, and a needle insertion mechanism (NIM). The container has an inner volume to contain a medicament which is urged out of the container by the activation mechanism. The needle insertion mechanism (NIM) is operably coupled with the activation mechanism and includes an actuation assembly adapted to insert a needle and a cannula to deliver the medicament from the container. The actuation assembly is movable between a storage state, a first operational state, a second operational state, and a third operational state to selectively position the needle and the cannula.

Abstract: Systems and methods perform selective rate limiting with a distributed set of agents and a remote controller. An agent receives a packet from a client, and inspects the packet using different rules. Each rule may include at least one different (i) rule definition with traffic dimensions identifying a different attack, (ii) signal with which to identify attack traffic matching the rule definition, (iii) threshold specifying a condition, and (iv) action to implement based on the condition of the threshold being satisfied. The agent provides the signal in response to the packet matching the traffic dimensions from the rule definition of a particular rule. The controller updates a value linked to the signal and a client identifier of the client, and implements the action of the particular rule across the distributed set of agents in response to the value satisfying the condition for the particular rule threshold.

Abstract: A fishing wader with a body portion and a pair of booties. The body portion has a front pocket assembly made of three stacked layers of material, including an outer layer having a plurality of hexagonal-shaped holes, a water-permeable middle layer, and a water-permeable inner layer. Each bootie has a toe piece, an ankle piece, and a sole piece. The toe piece has a top layer that is a laminated composite material including a waterproof breathable membrane. The toe piece also has a middle layer that is made of a durable and resilient waterproof material with a plurality of cutouts that penetrate completely through the middle layer. The toe piece also has a bottom layer. The durometer of the sole piece is preferably higher than the durometer of the toe and ankle pieces.

Abstract: A drug delivery device includes a housing defining a shell, a drug delivery assembly at least partially disposed within the housing, a cap defining an opening and being adapted to at least partially cover an end of the housing, at least one electronic component, a power source which powers the at least one electronic component, and a switch assembly. The drug delivery assembly comprises a guard which engages an inner surface of the housing and is movable between a first position, a second position, and a third position relative to the housing and is adapted to restrict external contact with a cannula. The switch assembly causes the power source to provide power to the at least one electronic component when the cap is removed from the housing, restrict the power source from providing power when the cap is coupled to the housing and the guard is in the first position, and cause the power source to provide power when the cap is coupled to the housing and the guard is in the third position.

Abstract: A fishing wader with a body portion and a pair of booties. The body portion has a front pocket assembly made of three stacked layers of material, including an outer layer having a plurality of hexagonal-shaped holes, a water-permeable middle layer, and a water-permeable inner layer. Each bootie has a toe piece, an ankle piece, and a sole piece. The toe piece has a top layer that is a laminated composite material including a waterproof breathable membrane. The toe piece also has a middle layer that is made of a durable and resilient waterproof material with a plurality of cutouts that penetrate completely through the middle layer. The toe piece also has a bottom layer. The durometer of the sole piece is preferably higher than the durometer of the toe and ankle pieces.

Abstract: An insertion/retraction mechanism for a drug delivery device is disclosed. The insertion/retraction mechanism includes a retraction hub, an insertion hub, an insertion/retraction mechanism housing, and a dual torsion spring system. The retraction hub includes a first primary rotational stop and a second primary rotational stop extending radially inwardly from an inside surface. The insertion hub is disposed inside the retraction hub and comprises a first complementary rotational stop and a second complementary rotational stop extending radially outwardly from an outside surface.

Abstract: Modular fluid path assemblies are provided that include conduit, coupling, and needle portions of a fluid path fluidly coupled to an outlet of a container. The modular fluid path assemblies further include a needle shield having a tip of the needle embedded therein. So configured, in embodiments, the modular fluid path assemblies can be sterilized, a medicament can be filled in the container, and a stopper inserted in the container so that the pre-sterilized and pre-filled modular fluid path assemblies can have a closed container integrity (CCI) seal.

Abstract: Methods, devices, and components are provided to reduce tissue resistive pressure during a subcutaneous drug delivery operation by increasing the size of the injection cavity by partially retracting the drug delivery member after inserting the drug delivery member to a subcutaneous position. The drug delivery devices described herein include a motor operably coupled to a drug delivery member. The motor can be selectively activated by a controller to retract the drug delivery member a predetermined distance to relieve pressure in an injection cavity in a patient. A force sensor can provide the controller with a drug delivery member insertion force. The controller can then estimate a tissue resistive pressure based on the drug delivery member insertion force and determine the predetermined distance for the partial drug delivery member retraction based on the tissue resistive pressure.